FDA rejects Atara Biotherapeutics' EBVALLO drug application

Go back to FDA rejects Atara Biotherapeutics' EBVALLO drug application
(NASDAQ: ATRA) Delayed: 8.53 --0 (-0%)
Previous Close $8.53    52 Week High $40.80 
Open $8.53    52 Week Low $12.45 
Day High $8.53    P/E N/A 
Day Low $8.53    EPS $0.00 
Volume 108